Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Short Interest Update

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) was the recipient of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 702,600 shares, a growth of 1,984.9% from the October 15th total of 33,700 shares. Based on an average trading volume of 1,540,000 shares, the short-interest ratio is currently 0.5 days. Approximately 34.8% of the company’s shares are short sold.

Shuttle Pharmaceuticals Stock Down 1.7 %

NASDAQ:SHPH traded down $0.02 during trading hours on Wednesday, reaching $1.13. 39,620 shares of the stock were exchanged, compared to its average volume of 471,894. The stock has a 50-day simple moving average of $1.40. Shuttle Pharmaceuticals has a twelve month low of $1.03 and a twelve month high of $4.95.

Shuttle Pharmaceuticals (NASDAQ:SHPH) last posted its quarterly earnings data on Tuesday, September 3rd. The company reported ($0.96) earnings per share for the quarter.

About Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .